Logo image of CASK

HERITAGE DISTILLING HOLDING (CASK) Stock Fundamental Analysis

NASDAQ:CASK - Nasdaq - US42727R1041 - Common Stock - Currency: USD

0.6969  -0.03 (-3.49%)

After market: 0.7199 +0.02 (+3.3%)

Fundamental Rating

0

Overall CASK gets a fundamental rating of 0 out of 10. We evaluated CASK against 33 industry peers in the Beverages industry. CASK has a bad profitability rating. Also its financial health evaluation is rather negative. CASK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year CASK has reported negative net income.
CASK had a negative operating cash flow in the past year.
CASK Yearly Net Income VS EBIT VS OCF VS FCFCASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -13.47%, CASK is doing worse than 84.38% of the companies in the same industry.
Industry RankSector Rank
ROA -13.47%
ROE N/A
ROIC N/A
ROA(3y)-61.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CASK Yearly ROA, ROE, ROICCASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 100 -100

1.3 Margins

CASK has a Gross Margin of 25.54%. This is amonst the worse of the industry: CASK underperforms 90.63% of its industry peers.
CASK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CASK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.16%
GM growth 5YN/A
CASK Yearly Profit, Operating, Gross MarginsCASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200 -300 -400

0

2. Health

2.1 Basic Checks

CASK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CASK has been increased compared to 1 year ago.
The debt/assets ratio for CASK has been reduced compared to a year ago.
CASK Yearly Shares OutstandingCASK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M 4M 5M
CASK Yearly Total Debt VS Total AssetsCASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

CASK has an Altman-Z score of -5.84. This is a bad value and indicates that CASK is not financially healthy and even has some risk of bankruptcy.
CASK has a worse Altman-Z score (-5.84) than 84.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.84
ROIC/WACCN/A
WACC7.09%
CASK Yearly LT Debt VS Equity VS FCFCASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

2.3 Liquidity

CASK has a Current Ratio of 0.23. This is a bad value and indicates that CASK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CASK (0.23) is worse than 90.63% of its industry peers.
CASK has a Quick Ratio of 0.23. This is a bad value and indicates that CASK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.05, CASK is doing worse than 93.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.05
CASK Yearly Current Assets VS Current LiabilitesCASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

1

3. Growth

3.1 Past

CASK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.13%, which is quite impressive.
CASK shows a small growth in Revenue. In the last year, the Revenue has grown by 5.41%.
The Revenue has been growing slightly by 0.46% on average over the past years.
EPS 1Y (TTM)100.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-489.6%
Revenue 1Y (TTM)5.41%
Revenue growth 3Y0.46%
Revenue growth 5YN/A
Sales Q2Q%-36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CASK Yearly Revenue VS EstimatesCASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CASK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CASK Price Earnings VS Forward Price EarningsCASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CASK Per share dataCASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CASK!.
Industry RankSector Rank
Dividend Yield N/A

HERITAGE DISTILLING HOLDING

NASDAQ:CASK (8/8/2025, 8:22:28 PM)

After market: 0.7199 +0.02 (+3.3%)

0.6969

-0.03 (-3.49%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.13%
Inst Owner Change1.25%
Ins Owners16.91%
Ins Owner Change91.66%
Market Cap8.40M
AnalystsN/A
Price TargetN/A
Short Float %2.23%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS0.65
BVpS-0.03
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.54%
FCFM N/A
ROA(3y)-61.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.05
Altman-Z -5.84
F-Score4
WACC7.09%
ROIC/WACCN/A
Cap/Depr(3y)17.47%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-489.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.41%
Revenue growth 3Y0.46%
Revenue growth 5YN/A
Sales Q2Q%-36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.26%
OCF growth 3YN/A
OCF growth 5YN/A